Skip to content

Efficacy of microneeding plus mixed growth factors solutions derived from human mesenchymal stem cell for facial rejuvenation

Efficacy of microneeding plus mixed growth factors solutions derived from human mesenchymal stem cell for facial rejuvenation: a Randomized, Controlled, Blinded Split-Face Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013311
Enrollment
Unknown
Registered
2017-11-09
Start date
2017-08-02
Completion date
Unknown
Last updated
2017-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

?????

Interventions

Two groups:microneeding alone or combined with mixed growth factors

Sponsors

Beijing Friendship Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 35-60 years male and female; Understand trial procedure and content and sign informed consent voluntarily; 2. No active skin disease on the face; 3. No facial filler such as hyaluronic acid or laser/light treatment; 4. No oral steroids,collagen powder/liquid,or topical hyaluronic acid used in the last 3 monthes; 5. No skin whitening products in the last 2 weeks.

Exclusion criteria

Exclusion criteria: 1. She is pregnant or in breast-feeding period; 2. To be allergic to trial medicine or its ingredient. No facial filler such as hyaluronic acid or laser/light treatment; 3. She/he had severe cardiovascular, cerebrovascular, renal, hepatic or hematopoietic disease; 4. She/he is taking part in the other clinical trial.

Design outcomes

Primary

MeasureTime frame
skin pores;skin texture;skin winkle;UV spots;black brown spots;Erythema;skin hydration;skin transepidermal water loss;skin elasticity;skin melanin index;skin erythema index;

Countries

China

Contacts

Public ContactZhuo Fenglin

Beijing Friendship Hospital affiliated to Capital Medical University

zflsunny@hotmail.com+86 15910895068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026